212 related articles for article (PubMed ID: 17627707)
1. Efficacy of dosing and re-dosing of two oral fixed combinations of indomethacin, prochlorperazine and caffeine compared with oral sumatriptan in the acute treatment of multiple migraine attacks: a double-blind, double-dummy, randomised, parallel group, multicentre study.
Sandrini G; Cerbo R; Del Bene E; Ferrari A; Genco S; Grazioli I; Martelletti P; Nappi G; Pinessi L; Sarchielli P; Tamburro P; Uslenghi C; Zanchin G
Int J Clin Pract; 2007 Aug; 61(8):1256-69. PubMed ID: 17627707
[TBL] [Abstract][Full Text] [Related]
2. Indomethacin, alone and combined with prochlorperazine and caffeine, but not sumatriptan, abolishes peripheral and central sensitization in in vivo models of migraine.
Ghelardini C; Galeotti N; Grazioli I; Uslenghi C
J Pain; 2004 Oct; 5(8):413-9. PubMed ID: 15501422
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of a fixed combination of indomethacin, prochlorperazine, and caffeine versus sumatriptan in acute treatment of multiple migraine attacks: a multicenter, randomized, crossover trial.
Di Monda V; Nicolodi M; Aloisio A; Del Bianco P; Fonzari M; Grazioli I; Uslenghi C; Vecchiet L; Sicuteri F
Headache; 2003 Sep; 43(8):835-44. PubMed ID: 12940804
[TBL] [Abstract][Full Text] [Related]
4. Two replicate randomized, double-blind, placebo-controlled trials of the time to onset of pain relief in the acute treatment of migraine with a fast-disintegrating/rapid-release formulation of sumatriptan tablets.
Sheftell FD; Dahlöf CG; Brandes JL; Agosti R; Jones MW; Barrett PS
Clin Ther; 2005 Apr; 27(4):407-17. PubMed ID: 15922814
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of a fixed combination of indomethacin, prochlorperazine, and caffeine in the treatment of episodic tension-type headache: a double-blind, randomized, nimesulide-controlled, parallel group, multicentre trial.
Cerbo R; Centonze V; Grazioli I; Tavolato B; Trenti T; Uslenghi C; Sternieri E
Eur J Neurol; 2005 Oct; 12(10):759-67. PubMed ID: 16190913
[TBL] [Abstract][Full Text] [Related]
6. The central analgesia induced by antimigraine drugs is independent from Gi proteins: superiority of a fixed combination of indomethacin, prochlorperazine and caffeine, compared to sumatriptan, in an in vivo model.
Ghelardini C; Galeotti N; Vivoli E; Grazioli I; Uslenghi C
J Headache Pain; 2009 Dec; 10(6):435-40. PubMed ID: 19756945
[TBL] [Abstract][Full Text] [Related]
7. A double-blind placebo-controlled study assessing the efficacy and tolerability of 50 mg sumatriptan tablets in the acute treatment of migraine. Sumatriptan Tablets S2CM07 Study Group.
Savani N; Brautaset NJ; Reunanen M; Szirmai I; Ashford EA; Hassani H; Saiers J
Int J Clin Pract Suppl; 1999 Aug; 105():7-15. PubMed ID: 10692717
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of sumatriptan 50 mg in patients not responding to standard care, in the treatment of mild to moderate migraine. The Sumatriptan 50 mg Italian Study Group.
Pini LA; Fabbri L; Cavazzuti L
Int J Clin Pharmacol Res; 1999; 19(2):57-64. PubMed ID: 10669900
[TBL] [Abstract][Full Text] [Related]
9. Sumatriptan-naproxen and butalbital: a double-blind, placebo-controlled crossover study.
Derosier F; Sheftell F; Silberstein S; Cady R; Ruoff G; Krishen A; Peykamian M
Headache; 2012 Apr; 52(4):530-43. PubMed ID: 22103635
[TBL] [Abstract][Full Text] [Related]
10. Indomethacin/prochlorperazine/caffeine: a review of its use in the acute treatment of migraine and in the treatment of episodic tension-type headache.
Hoy SM; Scott LJ
CNS Drugs; 2011 Apr; 25(4):343-58. PubMed ID: 21425885
[TBL] [Abstract][Full Text] [Related]
11. Patient preference for oral sumatriptan 25 mg, 50 mg, or 100 mg in the acute treatment of migraine: a double-blind, randomized, crossover study. Sumatriptan Tablets S2CM11 Study Group.
Salonen R; Ashford EA; Gibbs M; Hassani H
Int J Clin Pract Suppl; 1999 Aug; 105():16-24. PubMed ID: 10692718
[TBL] [Abstract][Full Text] [Related]
12. A prospective, randomized trial of intravenous prochlorperazine versus subcutaneous sumatriptan in acute migraine therapy in the emergency department.
Kostic MA; Gutierrez FJ; Rieg TS; Moore TS; Gendron RT
Ann Emerg Med; 2010 Jul; 56(1):1-6. PubMed ID: 20045576
[TBL] [Abstract][Full Text] [Related]
13. The efficacy and tolerability of a fixed combination of acetylsalicylic acid, paracetamol, and caffeine in patients with severe headache: a post-hoc subgroup analysis from a multicentre, randomized, double-blind, single-dose, placebo-controlled parallel group study.
Diener HC; Peil H; Aicher B
Cephalalgia; 2011 Oct; 31(14):1466-76. PubMed ID: 21908446
[TBL] [Abstract][Full Text] [Related]
14. Oral sumatriptan for the acute treatment of probable migraine: first randomized, controlled study.
Tepper SJ; Cady R; Dodick D; Freitag FG; Hutchinson SL; Twomey C; Kuhn TA
Headache; 2006 Jan; 46(1):115-24. PubMed ID: 16412159
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of almotriptan 12.5 mg in achieving migraine-related composite endpoints: a double-blind, randomized, placebo-controlled study in patients controlled study in patients with previous poor response to sumatriptan 50 mg.
Diener HC
Curr Med Res Opin; 2005 Oct; 21(10):1603-10. PubMed ID: 16238900
[TBL] [Abstract][Full Text] [Related]
16. Sumatriptan and naproxen sodium for the acute treatment of migraine.
Smith TR; Sunshine A; Stark SR; Littlefield DE; Spruill SE; Alexander WJ
Headache; 2005 Sep; 45(8):983-91. PubMed ID: 16109111
[TBL] [Abstract][Full Text] [Related]
17. Oral sumatriptan for the acute treatment of migraine: evaluation of three dosage strengths.
Cutler N; Mushet GR; Davis R; Clements B; Whitcher L
Neurology; 1995 Aug; 45(8 Suppl 7):S5-9. PubMed ID: 7644082
[TBL] [Abstract][Full Text] [Related]
18. A randomized, double-blind, placebo-controlled trial of the efficacy and tolerability of a 4-mg dose of subcutaneous sumatriptan for the treatment of acute migraine attacks in adults.
Wendt J; Cady R; Singer R; Peters K; Webster C; Kori S; Byrd S
Clin Ther; 2006 Apr; 28(4):517-26. PubMed ID: 16750463
[TBL] [Abstract][Full Text] [Related]
19. Promethazine plus sumatriptan in the treatment of migraine: a randomized clinical trial.
Asadollahi S; Heidari K; Vafaee R; Forouzanfar MM; Amini A; Shahrami A
Headache; 2014 Jan; 54(1):94-108. PubMed ID: 24182419
[TBL] [Abstract][Full Text] [Related]
20. Patient-selected dosing in a six-month open-label study evaluating oral sumatriptan in the acute treatment of migraine. Sumatriptan Tablets S2CM10 Study Group.
Dowson AJ; Ashford EA; Prendergast S; Hassani H; Roberts GW; Flöter T; Szczudlik A
Int J Clin Pract Suppl; 1999 Aug; 105():25-33. PubMed ID: 10692719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
